CHARLES SCHWAB INVESTMENT MANAGEMENT INC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 41 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$95,000
-60.9%
74,9200.0%0.00%
Q4 2018$243,000
+113.2%
74,920
+59.7%
0.00%
Q3 2018$114,000
-13.0%
46,9000.0%0.00%
Q2 2018$131,000
+50.6%
46,900
+156.3%
0.00%
Q1 2018$87,000
-18.7%
18,3000.0%0.00%
Q4 2017$107,000
+174.4%
18,3000.0%0.00%
Q3 2017$39,000
-54.7%
18,3000.0%0.00%
Q2 2017$86,000
-61.3%
18,300
-35.3%
0.00%
Q1 2017$222,000
-36.0%
28,3000.0%0.00%
Q4 2016$347,000
+122.4%
28,300
+183.0%
0.00%
Q3 2016$156,000
+27.9%
10,0000.0%0.00%
Q2 2016$122,00010,0000.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2016
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders